COVID-19 Autopsy Findings: Systemic Impact on the Body

Autopsies revealed SARS-CoV-2 as a systemic vascular and inflammatory disease, not merely pneumonia. These findings reshaped understanding of pathophysiology and Long COVID mechanisms.

Pulmonary (Universal in Fatal Cases)

  • Diffuse Alveolar Damage (DAD): Hyaline membranes, pneumocyte hyperplasia, fibrin thrombi — classic ARDS pathology.
  • Microthrombosis: Fibrin/platelet microthrombi in alveolar capillaries, arterioles — hallmark.
  • Neovascularization: Intussusceptive angiogenesis (distinct from flu).
  • Viral persistence: RNA/protein in pneumocytes, macrophages weeks after symptom onset.

Cardiovascular

  • Myocarditis: Lymphocytic infiltration, myocyte necrosis (10–30% of autopsies); often subclinical.
  • Pericarditis: Fibrinous exudate.
  • Coronary thrombi: Acute MI without atherosclerosis.
  • Endotheliitis: Viral inclusion in endothelial cells; vWF elevation, complement deposition.

Renal

  • Acute Tubular Injury (ATI): Most common; ischemic + direct viral (ACE2+ proximal tubules).
  • Collapsing Glomerulopathy: APOL1 high-risk genotype associated; HIV-like pathology.
  • Microthrombi in glomerular/peritubular capillaries.

Hepatic

  • Macro/microvesicular steatosis, lobular inflammation, bile duct injury.
  • Ischemic hepatitis (shock liver) in critical illness.
  • Viral RNA in hepatocytes, cholangiocytes.

Neurological

  • Neuroinflammation: Microglial activation, astrogliosis, T-cell infiltration (brainstem, olfactory bulb).
  • Microhemorrhages: Cortical, subcortical; linked to coagulopathy.
  • No consistent viral encephalitis: RNA rarely in parenchyma; damage likely immune-mediated.
  • Olfactory mucosa: Viral replication in sustentacular cells → anosmia.

Other Systems

  • GI: Viral RNA in enterocytes; ischemic colitis, vasculitis.
  • Skin: Chilblains (COVID toes), vasculitis, livedo reticularis.
  • Lymphoid: Splenic atrophy, lymph node necrosis, hemophagocytosis.
  • Endocrine: Adrenal hemorrhage, thyroiditis, pancreatic injury.

Implications for Long COVID

  • Persistent viral reservoirs (gut, brain, lymph nodes) → chronic immune activation.
  • Endothelial dysfunction → microvascular ischemia, exercise intolerance.
  • Autoimmunity: molecular mimicry, epitope spreading.
  • Dysautonomia: brainstem/vagal involvement.

Therapeutic Insights

  • Anticoagulation (therapeutic vs. prophylactic) — trials evolved (REMAP-CAP, ACTIV-4).
  • Immunomodulation: dexamethasone (RECOVERY), tocilizumab, baricitinib — target hyperinflammation.
  • Antivirals early: reduce viral seeding to extrapulmonary sites.

Autopsies taught us: treat the endothelium, modulate immunity early, anticipate multi-organ sequelae.

Viral Infections - Related Articles